Showing results (21-30 of 160) with videos related to
Sort By:
Pageof 16
European Journal of Cancer (Oxford, England : 1990)|October 19, 2016
Treatment de-intensification strategies for head and neck cancerJacqueline R Kelly, Zain A Husain, Barbara BurtnessOral Oncology|November 5, 2019
Immunotherapy for head and neck cancer: Recent advances and future directionsJohn D Cramer, Barbara Burtness, Robert L FerrisCancer Metastasis Reviews|November 24, 2024
Vaping and tumor metastasis: current insights and progressYibo Xi, Lei Yang, Barbara Burtness, et al.Cancers of the Head & Neck|May 12, 2020
Applications of radiomics in precision diagnosis, prognostication and treatment planning of head and neck squamous cell carcinomasStefan P Haider, Barbara Burtness, Wendell G Yarbrough, et al.Head & Neck|April 30, 2022
Efficacy and toxicity of weekly paclitaxel, carboplatin, and cetuximab as induction chemotherapy or in cases of metastases or relapse for head and neck cancer with a focus on elderly or frail patientsRebecca Forman, Hari Deshpande, Barbara Burtness, et al.Clinical Colorectal Cancer|December 17, 2005
Oxaliplatin induces a delayed immune-mediated hemolytic anemia: a case report and review of the literatureVanita Noronha, Barbara Burtness, John Murren, et al.Nature Reviews. Clinical Oncology|June 14, 2019
The changing therapeutic landscape of head and neck cancerJohn D Cramer, Barbara Burtness, Quynh Thu Le, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 29, 2022
Current Therapy for Metastatic Head and Neck Cancer: Evidence, Opportunities, and ChallengesTrisha M Wise-Draper, Houda Bahig, Marion Tonneau, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: an Eastern Cooperative Oncology Group studyBarbara Burtness, Meredith A Goldwasser, William Flood, et al.Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|April 4, 2003
Doxorubicin cardiotoxicity: prevention of congestive heart failure with serial cardiac function monitoring with equilibrium radionuclide angiocardiography in the current eraIsao Mitani, Diwakar Jain, Tammy M Joska, et al.Pageof 16